Product
SIM0417/Ritonavir
1 clinical trial
1 indication
Indication
ElderClinical trial
A Single Center, Non-randomized, Open-label Phase I Study to Investigate the Pharmacokinetics and Safety of SIM0417/Ritonavir After Single Dose Administration in Healthy Elderly SubjectsStatus: Recruiting, Estimated PCD: 2023-09-30